Sign in
TerminatedNo phase

Long-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product.

Key facts

Who runs it
Mustang Bio
Where
Boston, Cleveland, Orange, Rochester, and Seattle, United StatesSee the 5 sites
Trial code
Status
Terminated
People taking part
3 people enrolled
Started
29 Sept 2021
Ended
12 Apr 2024
Type of study
Observational, 2 groups
Treatments tested
  • Prior MB-102 CAR-T cell investigational product.
  • Prior MB-106 CAR-T cell investigational product.
Record updated
22 July 2024
Why it stopped
Business Reasons

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • Patients previously treated with a Mustang Bio CAR-T cell investigational product in a prior Mustang Bio sponsored clinical study
  • Patient has provided signed and dated informed consent

Who cannot take part

  • None. All patients who have received prior treatment with Mustang Bio CAR-T cell investigational product in a Mustang Bio sponsored clinical study are eligible for this long-term follow up (LTFU) study

Where in United States

  • Massachusetts General HospitalBoston, United States
  • Cleveland ClinicCleveland, United States
  • UC Irvine Health- Chao Family Comprehensive Cancer CenterOrange, United States
  • University of Rochester Medical CenterRochester, United States
  • Fred Hutchinson Cancer CenterSeattle, United States

About the trial

What the trial wants to find out

A long-term follow-up study to assess safety and efficacy in patients previously treated with Mustang Bio chimeric antigen receptor (CAR)-T cell investigational products.

The 2 groups in the trial

  • Prior MB-102 CAR-T cell investigational product.

    Patients previously treated with MB-102 CAR-T cell investigational product.

  • Prior MB-106 CAR-T cell investigational product.

    Patients previously treated with MB-106 CAR-T cell investigational product.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Long-term Follow-up Study in Patients Previously Treated With Mustang Bio, Inc. CAR-T Cell Investigational Products
Record updated
22 July 2024